Moreover, our observation that CDF modulates miR-21-PTEN-Akt axis in both p53-positive and p53-negative colon cancer cells suggests that CDF could be therapeutically effective in p53-positive and negative colon tumors. Here, TP53 is linked to colonic neoplasm.